Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness

Background Onchocerciasis, also known as “river blindness”, is caused by the bite of infected female blackflies (genus Simuliidae) that transmit the parasite Onchocerca volvulus. A high onchocerciasis microfarial load increases the risk to develop epilepsy in children between the ages of 3 and 18 years. In resource-limited settings in Africa where onchocerciasis has been poorly controlled, high numbers of onchocerciasis-associated epilepsy (OAE) are reported. We use mathematical modeling to predict the impact of onchocerciasis control strategies on the incidence and prevalence of OAE. Methodology We developed an OAE model within the well-established mathematical modelling framework ONCHOSIM. Using Latin-Hypercube Sampling (LHS), and grid search technique, we quantified transmission and disease parameters using OAE data from Maridi County, an onchocerciasis endemic area, in southern Republic of South Sudan. Using ONCHOSIM, we predicted the impact of ivermectin mass drug administration (MDA) and vector control on the epidemiology of OAE in Maridi. Principal findings The model estimated an OAE prevalence of 4.1% in Maridi County, close to the 3.7% OAE prevalence reported in field studies. The OAE incidence is expected to rapidly decrease by >50% within the first five years of implementing annual MDA with good coverage (≥70%). With vector control at a high efficacy level (around 80% reduction of blackfly biting rates) as the sole strategy, the reduction is slower, requiring about 10 years to halve the OAE incidence. Increasing the efficacy levels of vector control, and implementing vector control simultaneously with MDA, yielded better results in preventing new cases of OAE. Conclusions/Significances Our modeling study demonstrates that intensifying onchocerciasis eradication efforts could substantially reduce OAE incidence and prevalence in endemic foci. Our model may be useful for optimizing OAE control strategies.

[1]  R. Post,et al.  “Slash and Clear”, a Community-Based Vector Control Method to Reduce Onchocerciasis Transmission by Simulium sirbanum in Maridi, South Sudan: A Prospective Study , 2021, Pathogens.

[2]  L. Coffeng,et al.  The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030 , 2021, PLoS neglected tropical diseases.

[3]  L. Coffeng,et al.  How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? , 2021, PLoS neglected tropical diseases.

[4]  P. Preux,et al.  Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation , 2021, PLoS neglected tropical diseases.

[5]  N. Brattig,et al.  Onchocerciasis (River Blindness) - more than a Century of Research and Control. , 2020, Acta tropica.

[6]  R. Colebunders,et al.  Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies. , 2020, The Lancet. Infectious diseases.

[7]  R. Colebunders,et al.  Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection. , 2020, Epileptic disorders : international epilepsy journal with videotape.

[8]  M. Boussinesq,et al.  A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy , 2020, Open forum infectious diseases.

[9]  R. Colebunders,et al.  The Role of the Maridi Dam in Causing an Onchocerciasis-Associated Epilepsy Epidemic in Maridi, South Sudan: An Epidemiological, Sociological, and Entomological Study , 2020, Pathogens.

[10]  P. Preux,et al.  Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control , 2020, International health.

[11]  R. Colebunders,et al.  Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures , 2020, Infectious Diseases of Poverty.

[12]  E. Beghi The Epidemiology of Epilepsy , 2019, Neuroepidemiology.

[13]  R. Colebunders,et al.  Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania. , 2019, Epileptic disorders : international epilepsy journal with videotape.

[14]  M. Basáñez,et al.  From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes , 2019, PLoS neglected tropical diseases.

[15]  A. Hotterbeekx,et al.  Neurological manifestations in Onchocerca volvulus infection: A review , 2019, Brain Research Bulletin.

[16]  R. Colebunders,et al.  Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon , 2019, Epilepsy & Behavior.

[17]  R. Colebunders,et al.  High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey , 2018, Seizure.

[18]  M. Boussinesq,et al.  Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin , 2018, Infectious Diseases of Poverty.

[19]  F. Wit,et al.  The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol , 2018, Infectious Diseases of Poverty.

[20]  R. Colebunders,et al.  Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan , 2018, Seizure.

[21]  M. Boussinesq,et al.  The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study. , 2018, The Lancet. Infectious diseases.

[22]  L. Coffeng,et al.  Burden of onchocerciasis-associated epilepsy: first estimates and research priorities , 2018, Infectious Diseases of Poverty.

[23]  A. Laudisoit,et al.  High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo , 2018, Infectious Diseases of Poverty.

[24]  B. Boatin,et al.  Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes , 2018, Infectious Diseases of Poverty.

[25]  R. Colebunders,et al.  High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin , 2018, Infectious Diseases of Poverty.

[26]  Young Eun Kim,et al.  How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  R. Colebunders,et al.  Onchocerciasis-Associated Epilepsy, an Additional Reason for Strengthening Onchocerciasis Elimination Programs. , 2017, Trends in parasitology.

[28]  P. Wolf,et al.  Juvenile myoclonic epilepsy as a spectrum disorder: A focused review , 2017, Seizure.

[29]  J. Sejvar,et al.  Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus , 2017, Science Translational Medicine.

[30]  M. Oijen,et al.  Nodding Syndrome in Onchocerciasis Endemic Areas. , 2016, Trends in parasitology.

[31]  A. Laudisoit,et al.  Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda , 2016, BMC Research Notes.

[32]  L. Coffeng,et al.  Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis , 2015, Parasites & Vectors.

[33]  L. Coffeng,et al.  Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment , 2014, PloS one.

[34]  Pierre-Marie Preux,et al.  Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa , 2014, The Lancet Neurology.

[35]  P. Diggle,et al.  The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected , 2014, Parasites & Vectors.

[36]  P. Enyong,et al.  The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment , 2014, Parasites & Vectors.

[37]  B. Lowe,et al.  Exposure to Multiple Parasites Is Associated with the Prevalence of Active Convulsive Epilepsy in Sub-Saharan Africa , 2014, PLoS neglected tropical diseases.

[38]  M. Anker,et al.  Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan. , 2013, African health sciences.

[39]  P. Preux,et al.  Epilepsy in Onchocerciasis Endemic Areas: Systematic Review and Meta-analysis of Population-Based Surveys , 2009, PLoS neglected tropical diseases.

[40]  B. Boatin The Current State of the Onchocerciasis Control Programme in West Africa , 2003, Tropical doctor.

[41]  M. Boussinesq,et al.  Demographic Impact of Epilepsy in Africa: Results of a 10‐year Cohort Study in a Rural Area of Cameroon , 2003, Epilepsia.

[42]  M. Boussinesq,et al.  Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[43]  M. Murdoch,et al.  Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa , 2002, Annals of tropical medicine and parasitology.

[44]  J D Habbema,et al.  Epidemiological modelling for onchocerciasis control. , 1992, Parasitology today.

[45]  L. Coffeng,et al.  River Blindness: Mathematical Models for Control and Elimination. , 2016, Advances in parasitology.

[46]  Josemir W Sander,et al.  Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: , 2013 .

[47]  J D Habbema,et al.  ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. , 1990, Computer methods and programs in biomedicine.